---
layout: splash
title: 대웅제약 (069620)
excerpt: 대웅제약의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 118,800 | <span style="color: tomato">0.9<small>%</small></span> | P:의약품 | 31.1 | 2.2 | 0.5<small>%</small> |

<!-- more -->

<br>
> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 양약,의료기기 제조/화장품,의약부의품 도소매/부동산 임대 |
| <span style="white-space:nowrap;">**상장일**</span> | 2002년 11월 1일 |
| <span style="white-space:nowrap;">**결산월**</span> | 12월 |
| <span style="white-space:nowrap;">**대표자**</span> | 전승호, 이창재 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.daewoong.co.kr](http://www.daewoong.co.kr){target="_blank"} |

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;05 | | [영업(잠정)실적(공정공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240205800632){:target="_blank"} |
|  | | [매출액또는손익구조30%(대규모법인은15%)이상변경              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240205800499){:target="_blank"} |
| 02&#x2011;01 | | [[기재정정]단일판매ㆍ공급계약체결](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240201800692){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![069620](/stock/images/069620.png){: .align-center}

<br>
> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 118,800 | <span style="color: tomato">0.9<small>%</small></span> | <span style="color: tomato">8.0<small>%</small></span> | <span style="color: tomato">4.8<small>%</small></span> | <span style="color: tomato">11.7<small>%</small></span> | <span style="color: tomato">7.3<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-23.0<small>%</small></span> | 36.6<small>%</small> | -0.63 | -40.5<small>%</small> | -29.5<small>%</small> | 0.6 |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 31.1 | 2.2 | 0.5<small>%</small> | - |

<br>
> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/069620/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=069620){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A069620&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=069620){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/069620){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/069620/financial-summary){:target="_blank"} |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![069620](/stock/images/069620_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -23.0<small>%</small> | 36.6<small>%</small> | -0.63 | -40.5<small>%</small> | -29.5<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 9.8<small>%</small> | 33.5<small>%</small> | 0.29 | -19.1<small>%</small> | -6.4<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -28.5<small>%</small> | 27.5<small>%</small> | -1.04 | -36.8<small>%</small> | -27.1<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -12.2<small>%</small> | 27.3<small>%</small> | -0.45 | -27.1<small>%</small> | -21.4<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -30.3<small>%</small> | 27.0<small>%</small> | -1.12 | -33.2<small>%</small> | -24.9<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -29.3<small>%</small> | 26.7<small>%</small> | -1.10 | -34.6<small>%</small> | -25.0<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -9.9<small>%</small> | 15.3<small>%</small> | -0.65 | -20.5<small>%</small> | -6.9<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 4.0<small>%</small> | 8.7<small>%</small> | 0.46 | -7.7<small>%</small> | -0.5<small>%</small> |
| MACD[^fn_tech_metric_macd] | -21.8<small>%</small> | 28.8<small>%</small> | -0.76 | -29.2<small>%</small> | -22.6<small>%</small> |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![069620](/stock/images/069620_corr.png){: .align-center}

|       | [녹십자홀딩스](/005250/) | [대웅](/003090/) | [CJ대한통운](/000120/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [동국제약](/086450/) | [SK](/034730/) | [삼성물산](/028260/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![069620](/stock/images/069620_2x.png){: .align-center}

<br>
> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}